Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Turalio (pexidartinib) for the Treatment of Tenosynovial Giant Cell Tumour

Drug Name

Turalio™ (pexidartinib)

Developer

Daiichi Sankyo, Plexxikon

Therapy Class

Kinase inhibitor

Product Description

Colony-stimulating factor 1 receptor (CSF1R)-targeting tyrosine kinase inhibitor

Current Indication

Tenosynovial giant cell tumour

Market Sector

Oncology

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top